Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile

Published:2019-01-18 Issue:3 Volume:8 Page:1124-1134
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Weber Manuel¹^ORCID,Wehrhan Falk¹,Baran Christoph¹,Agaimy Abbas²,Büttner‐Herold Maike³,Kesting Marco¹,Ries Jutta¹

Affiliation:

1. Department of Oral and Maxillofacial Surgery Friedrich‐Alexander University Erlangen‐Nürnberg (FAU) Erlangen Germany

2. Institute of Pathology Friedrich‐Alexander University Erlangen‐Nürnberg (FAU) Erlangen Germany

3. Institute of Pathology, Department of Nephropathology Friedrich‐Alexander University Erlangen‐Nürnberg (FAU) Erlangen Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.1929

Reference40 articles.

1. Current concepts for the management of head and neck cancer: Chemotherapy

2. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

3. Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians

4. The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

5. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer – detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients’ peripheral blood;Frontiers in Oncology;2024-09-13

2. Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case;Frontiers in Oncology;2024-07-15

3. The Immune Checkpoint BTLA in Oral Cancer: Expression Analysis and Its Correlation to Other Immune Modulators;International Journal of Molecular Sciences;2024-06-15

4. The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers;Biomedicine & Pharmacotherapy;2024-02

5. Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO;Frontiers in Oncology;2023-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3